Tariffs and Trade Series: What Senior Management Teams Need to Know
No Password Required: CEO of HACKERverse.ai, Disruptor of Cybersecurity Sales and Most Other Things
Compliance Tip of the Day: Multiplying the Influence of Compliance
Daily Compliance News: May 13, 2025, The Leaving on a Jet Plane Edition
Compliance tip of the Day: Communication Through Persuasion
FCPA Compliance Report: Upping Your Game in Compliance
Episode 368 — LRN Issues New Report Highlighting Growing Gap in Compliance Program Performance
Compliance Tip of the Day: Empowering Middle Managers to Drive Compliance Transformation
Creativity and Compliance: From Compliance Enforcers to Trusted Advisors: The Path Forward
Top Healthcare Compliance Priorities for 2025
Compliance Tip of the Day: Middle Managers as the Eyes and Ears of Compliance
ADA Compliance for Medical and Dental Practices: Responding to Inquiries and Investigations
Innovation in Compliance: Exploring the Intersection of Compliance, Technology, and AI with Ben Sperry
What Every Law Firm Leader Can Learn from Law Day and the Perkins Coie Ruling: On Record PR
Compliance Tip of the Day: Elevating Compliance Through Connected Middle Managers
Compliance into the Weeds: USRA Declination Case Study - Self-Disclosure Best Practices
Compliance Tip of the Day: Middle Managers as Ethical Cornerstones
Understanding Human Trafficking and Modern Slavery: A Business Imperative with Clint Palermo
SBR Author’s Podcast: Understanding Complexity with Dr. Jean Boulton, Part 2: The Power of Simple Principles in Ethics and Compliance
Daily Compliance News: May 6, 2025 the Made in China Edition
Commercially reasonable efforts (CRE) provisions are a common feature in technology and life sciences agreements, particularly in development collaborations, licensing deals, and milestone-based contracts. ...more
AI is poised to revolutionize drug discovery, but uncertainty in developing protectable IP in this emerging field creates a host of potential risks for companies innovating in this space. Further complicating things: not all...more
One of the greatest fears of a life sciences company is the possibility of being sued for intellectual property violation shortly before their IPO. Such a lawsuit can destabilize market confidence in the company, raise...more